Accepted at 6:56 p.m. Nov, 29, 2024 by IantheBFG
Author: IantheBFG
Related Note: 1462849421840 1
Rationale for change

Old notes I added to my lecture notes, thought they would be useful in extra field.

gliptin -> glip in -> inhibit DPP-4 the increase GLP-1

I missed an NMBE form step 1 question because these drugs increase endogenous release of insulin so that's where the second part comes from

Extra Extra
Text
Linagliptin, saxagliptin, and sitagliptin are all examples of {{c1::DPP-4 inhibitors}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy




Watch Insulin, Sulfonylureas, Meglitinides, GLP-1 Agonists, DPP-4 Inhibitors
Sketchy 2


Watch Diabetes Management
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize


Physeo

Bootcamp
Watch associated Bootcamp video - Diabetes Type 2 Management
OME

Additional Resources

One by one
Empty field
#AK_Step1_v12::#Bootcamp::Endocrinology::07_Pancreas::09_Diabetes_Type_2_Management #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::02_Diabetes_Management #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::02_Diabetes::01_Insulin,_sulfonylureas,_meglitinides,_GLP-1_agonists,_DPP-4_inhibitors #AK_Step1_v12::#Pixorize::03_Pharmacology::08_Diabetes_Drugs_(Old)::08_DPP-4_Inhibitors #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step2_v12::#B&B::04_Endocrinology::03_Diabetes::05_Diabetes_Treatment::Extra #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#OME::PreClinical::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #PANCE::EOR::IM #AK_Step1_v12::#Physeo::03_Physiology::06_Endocrinology::05_Insulin_&_Glucagon #AK_Original_Decks::Step_1::Zanki_Pharmacology !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::07_Diabetes_Drugs_(New)::01_DPP-4_Inhibitors #PANCE::EOR::PEDS #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::06_DDP-4_Inhibitors #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::01_Diabetes_mellitus_therapy::*DPP-4_Inhibitors #AK_Step1_v12::#OME::04_Organ_Systems::06_Endocrine::05_Pancreas::03_Diabetes_Pharmacology #PANCE::ENDO::diabetes